Last reviewed · How we verify
CodaVax-H1N1 influenza vaccine
CodaVax-H1N1 influenza vaccine is a Biologic drug developed by Codagenix, Inc. It is currently in Phase 1 development.
At a glance
| Generic name | CodaVax-H1N1 influenza vaccine |
|---|---|
| Sponsor | Codagenix, Inc |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Intramuscular CodaVax-H1N1 in Healthy Adults (PHASE1)
- Safety Study of Live Attenuated Influenza Vaccine, CodaVax, Delivered Via Intranasal Spray (PHASE1)
- Safety Study of Live Attenuated Influenza Vaccine, CodaVax (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- CodaVax-H1N1 influenza vaccine CI brief — competitive landscape report
- CodaVax-H1N1 influenza vaccine updates RSS · CI watch RSS
- Codagenix, Inc portfolio CI
Frequently asked questions about CodaVax-H1N1 influenza vaccine
What is CodaVax-H1N1 influenza vaccine?
CodaVax-H1N1 influenza vaccine is a Biologic drug developed by Codagenix, Inc.
Who makes CodaVax-H1N1 influenza vaccine?
CodaVax-H1N1 influenza vaccine is developed by Codagenix, Inc (see full Codagenix, Inc pipeline at /company/codagenix-inc).
What development phase is CodaVax-H1N1 influenza vaccine in?
CodaVax-H1N1 influenza vaccine is in Phase 1.
Related
- Manufacturer: Codagenix, Inc — full pipeline
- Compare: CodaVax-H1N1 influenza vaccine vs similar drugs
- Pricing: CodaVax-H1N1 influenza vaccine cost, discount & access